| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.3M | +1056.7% |
| Cost of Revenue | $7.1M | +269.1% |
| Gross Profit | $1.2M | -18.8% |
| R&D Expense | $514K | +96.1% |
| SG&A Expense | $8.1M | +188.7% |
| Operating Income | -$13.3M | -105.7% |
| Net Income | -$17.5M | -593.0% |
| EPS (Basic) | -$1.02 | -363.6% |
| EPS (Diluted) | -$1.02 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $548K | -43.7% |
| Inventory | $1.3M | -45.0% |
| Current Assets | $3.0M | -35.9% |
| Total Assets | $9.4M | -44.9% |
| Current Liabilities | $10.3M | +301.6% |
| Total Liabilities | $14.5M | +108.7% |
| Stockholders' Equity | -$5.0M | -149.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.4M | +30.1% |
| Investing Cash Flow | -$19K | +98.0% |
| Financing Cash Flow | $6.5M | +46.7% |
| -363.6% |